Announcements Trials
Browse Landscape

Phase

Phase 3 7Phase 2 7Phase NA 2Phase 4 2Phase 1/2 2Phase EARLY_PHASE1 1Phase 1 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Endocrine 1

Conditions

Recombinant Human Thyroid Stimulating Hormone 1DTC - Differentiated Thyroid Cancer 1

Interventions

Radiotherapy 26Standard of Care 25Surveys and Questionnaires 22Blood Specimen Collection 21Cisplatin 20Radiotherapy, Intensity-Modulated 19Magnetic Resonance Spectroscopy 19Biopsy 15Practice Guidelines as Topic 13Low-Level Light Therapy 13Exercise 10X-Rays 9Surgical Procedures, Operative 9Radiosurgery 9Interviews as Topic 9Therapeutics 8Magnetic Resonance Imaging 8Saline Solution 7Radiofrequency Ablation 7Radiation 7Fluorodeoxyglucose F18 7Transcutaneous Electric Nerve Stimulation 6Thyroidectomy 6Immunohistochemistry 6Educational Status 6Control Groups 6Chemoradiotherapy 6Cetuximab 6Biopsy, Fine-Needle 6Acupuncture Therapy 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Thyrotropin Alfa × Head & Neck × Clear all
NCT06431620 2024-05-28

Safety and Efficacy of Recombinant Human Thyroid Stimulating Hormone for Adjuvant Diagnosis in Patients With Locally Advanced/Metastatic Differentiated Thyroid Cancer

Nanjing First Hospital, Nanjing Medical University

Phase NA Recruiting
15 enrolled
Head & Neck

Recombinant Human Thyroid Stimulating Hormone

NCT06405217 2024-05-08

Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment

Nanjing First Hospital, Nanjing Medical University

Phase NA Recruiting
30 enrolled
EndocrineHead & Neck

DTC - Differentiated Thyroid Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡